Results of using the neuroprotective drug Cellex in non-traumatic intracranial hemorrhage
Introduction. In the Russian Federation, neuroprotective agents are widely used in the treatment of patients with ischemic stroke. There are accumulated data on the efficacy and safety of the neuroprotective agent Cellex® in ischemic stroke. The use of this drug in hemorrhagic stroke has been studie...
Главные авторы: | Kh. D. Mongush, A. V. Kyrgys, A. A. Sedip, A. E. Shyyrap, A. B. Ondar, M. G. Zhestikova |
---|---|
Формат: | Статья |
Язык: | Russian |
Опубликовано: |
Remedium Group LLC
2022-03-01
|
Серии: | Медицинский совет |
Предметы: | |
Online-ссылка: | https://www.med-sovet.pro/jour/article/view/6755 |
Схожие документы
-
Efficacy of Cellex in patients with mild cognitive impairment
по: B. A. Abusueva, и др.
Опубликовано: (2019-04-01) -
NEUROPROTECTION INFLUENCE ON COURSE OF CEREBRAL STROKE
по: G. N. BELSKAYA, и др.
Опубликовано: (2016-12-01) -
Neuroprotection by Ozanimod Following Intracerebral Hemorrhage in Mice
по: Fei Wang, и др.
Опубликовано: (2022-06-01) -
Drug-induced non-traumatic intracranial hemorrhage associated with the use of anticoagulants and antiplatelet agents
по: O. D. Ostroumova, и др.
Опубликовано: (2022-12-01) -
Acute albumin administration as therapy for intracerebral hemorrhage: A literature review
по: Yirong Cao, и др.
Опубликовано: (2024-01-01)